Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Blood Advances
|
October 31, 2025
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Daniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.
Transplantation and Cellular Therapy
|
April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Blood Neoplasia
|
March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood Advances
|
August 14, 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, et al.
Blood
|
July 12, 2024
Risk prediction for clonal cytopenia: multicenter real-world evidence
Zhuoer Xie, Rami Komrokji, Najla Al Ali, et al.
Haematologica
|
February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
The Lancet. Haematology
|
August 12, 2023
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
Rory M Shallis, Naval Daver, Jessica K Altman, et al.
Leukemia
|
October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
American Journal of Hematology
|
June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Blood Cancer Journal
|
June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database
Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Blood Advances
|
October 31, 2025
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
Daniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.
Transplantation and Cellular Therapy
|
April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Blood Neoplasia
|
March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood Advances
|
August 14, 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, et al.
Blood
|
July 12, 2024
Risk prediction for clonal cytopenia: multicenter real-world evidence
Zhuoer Xie, Rami Komrokji, Najla Al Ali, et al.
Haematologica
|
February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
The Lancet. Haematology
|
August 12, 2023
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
Rory M Shallis, Naval Daver, Jessica K Altman, et al.
Leukemia
|
October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
American Journal of Hematology
|
June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Blood Cancer Journal
|
June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database
Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Page
of 12